Now Playing
Opinion|Videos|June 21, 2024
Tackling Key Concerns in Atopic Dermatitis + Biologic Use
Casey Butrus, PharmD; Michael Cameron, MD, FAAD, and Brittany Craiglow, MD, address the critical clinical challenges in treating atopic dermatitis (AD) patients and discuss current trends in biologics use for AD.
Advertisement
Episodes in this series
- As it relates to the current treatment landscape for atopic dermatitis, what are the most pressing clinical concerns in treating patients with this disease?
- What trends are you seeing related to the use of biologics and injectables in the management of AD, and what are the cost implications of these trends?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment
2
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
3
Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations
4
New Dermatologic Therapies Make Waves at Maui Derm 2026
5
